<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Evoq Remedies Limited has filed a disclosure with BSE confirming that it does not qualify as a 'Large Corporate' under SEBI regulations for debt securities issuance. The filing dated April 30, 2026, cites two SEBI circulars from August 2021 and October 2023. As per the attached Annexure-A, the company's outstanding borrowing as of March 31, 2026 is Nil, and it has no credit rating since it has not raised debt. The company has confirmed it falls below the threshold criteria to be classified as a Large Corporate. Managing Director Bhumishth Patel signed the disclosure digitally.
This is a routine compliance filing and has no direct impact on shareholders or stock price. The Nil borrowing status indicates the company has no outstanding debt, suggesting conservative financial management with low leverage risk.